Patents by Inventor Andrew W. Miller

Andrew W. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAS TURBINE ENGINE WITH ACOUSTIC SPACING OF THE FAN BLADES AND OUTLET GUIDE VANES
    Publication number: 20240151185
    Abstract: A gas turbine engine comprises a fan, a core turbine engine coupled to the fan, a fan case housing the fan and the core turbine engine, a plurality of outlet guide vanes extending between the core turbine engine and the fan case, and an acoustic spacing. The fan comprises a plurality of fan blades that define a fan diameter and a BEAL. The fan case comprises an inlet and an inlet length between the inlet and the fan. The acoustic spacing comprises a distance between the fan and the plurality of outlet guide vanes, and in combination with the BEAL determines an acoustic spacing ratio of the gas turbine engine.
    Type: Application
    Filed: November 3, 2022
    Publication date: May 9, 2024
    Applicant: General Electric Company
    Inventors: Brandon Wayne Miller, Egbert Geertsema, Arthur W. Sibbach, Andrew Hudecki, Timothy Richard DePuy, John C. Schilling, Frank Worthoff, Tsuguji Nakano
  • Pyrazolopyrazine kinase inhibitors
    Patent number: 8895740
    Abstract: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: November 25, 2014
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Juan-Miguel Jimenez, Luca Settimo, Damien Fraysse, Guy Brenchley, Christopher John Davis, Andrew W. Miller
  • Pyrazolopyrimidine kinase inhibitors
    Patent number: 8809335
    Abstract: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: August 19, 2014
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Juan-Miguel Jimenez, Luca Settimo, Damien Fraysse, Guy Brenchley, Christopher John Davis, Andrew W. Miller
  • PYRAZOLOPYRIMIDINE KINASE INHIBITORS
    Publication number: 20130053394
    Abstract: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
    Type: Application
    Filed: July 27, 2012
    Publication date: February 28, 2013
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Juan-Miguel Jimenez, Luca Settimo, Damien Fraysse, Guy Brenchley, Christopher John Davis, Andrew W. Miller
  • PYRAZOLOPYRIDINE KINASE INHIBITORS
    Publication number: 20130053395
    Abstract: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
    Type: Application
    Filed: July 27, 2012
    Publication date: February 28, 2013
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Juan-Miguel Jimenez, Julian M.C. Golec, Luca Settimo, Damien Fraysse, Guy Brenchley, Dean Boyall, Heather Twin, Stephen Young, Andrew W. Miller, Christopher John Davis, Philip N. Collier
  • PYRAZOLOPYRAZINE KINASE INHIBITORS
    Publication number: 20130053388
    Abstract: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
    Type: Application
    Filed: July 27, 2012
    Publication date: February 28, 2013
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Juan-Miguel Jimenez, Luca Settimo, Damien Fraysse, Guy Brenchley, Christopher John Davis, Andrew W. Miller
  • COLLABORATIVE INSTRUCTIONAL METHOD AND SYSTEM
    Publication number: 20120208163
    Abstract: A system and method for comprehensive, fully or partially automated instructional plan creation, management, and tracking is provided. Variations of the system may include specialized computer systems, specialized applications, or web-based server-side solutions. Variations of the method may include generation of integrated or course-based instructional plans based on a relationship between standards and indicators of educational success and an academic schedule divided into schedule units. Instructional plans may be populated with learning and teaching resources from a content repository. Such population may be automated, customized, based on user settings, and otherwise configurable on a per-instructor basis. Instructors may also load content into the repository, associate content with one or more identifying parameters, and collaborate with each-other based on teaching style and resource choices.
    Type: Application
    Filed: April 29, 2011
    Publication date: August 16, 2012
    Inventors: Karen E. Dwyer, Theresa A. Cepaitis, Carrie D. Booth, Margaret M. Gaudino, Gary P. Smith, Richard M. Jolles, David K. Kreisberg, Vivian C. Rosskamm, Andrew W. Miller, Maria L. Tarasuk